After the feasibility assessment, the decision may be made not to continue with the proposal, for example if:
- the study is deemed to be 'unfeasible' after consideration by the CI and the Clinical Division
- the site application to the sponsor is unsuccessful.
As many people will already have been involved in consultations, it is important to keep them informed of developments. In this case, the Clinical Division research manager will be responsible for sending an update to contributors.
|Where to find
|NIHR Clinical Trial Toolkit - abandon trial
|Prior to NIHR 70-day benchmark
|Process map links
|This activity occurs in the feasibility stage:
> Imperial College London as sponsor
> Imperial College Hospital NHS Trust as sponsor
> Commercial organisation as sponsor
> Non-commercial organisation as sponsor